Reporter March 16 2018
Mar. 15, 2018—A new integrated imaging approach makes it possible to probe the molecules involved in invasive infections and can be broadly applied to any health or disease state.
Mar. 15, 2018—Richard Peek, MD, director of the Vanderbilt Digestive Disease Research Center (VDDRC) and chief of the Division of Gastroenterology, Hepatology and Nutrition, has been appointed to serve on the advisory council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Mar. 15, 2018—K. Dane Wittrup, PhD, a pioneer in protein engineering technologies who has helped accelerate development of antibody therapies for cancer, will deliver the next Flexner Discovery Lecture on Thursday, March 22.
Mar. 15, 2018—Country music singers and friends of Monroe Carell Jr. Children’s Hospital at Vanderbilt Jake Owen and Lady Antebellum’s Charles Kelley, recently partnered with the new Topgolf Nashville location for the Children’s Cup, an evening of golf and music to benefit pediatric cancer research at Children’s Hospital.
Mar. 15, 2018—New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease.
Mar. 15, 2018—The Vanderbilt University School of Medicine student-run Shade Tree Clinic was founded in 2004 as a means to provide primary care to Nashville’s uninsured population and to allow medical and nursing students to receive valuable hands-on training while providing healthcare to those in need.
Mar. 15, 2018—Most preschool-age children manage to get enough recommended daily physical activity, but how they move varies with noticeable differences between boys and girls, a new Vanderbilt study found.
Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer
Mar. 14, 2018—New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.
Mar. 12, 2018—Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.